Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Gastroenterologia Y Hepatologia|July 13, 2025
EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti-tumor necrosis factor-α as first- or second-line biologic treatment among patients with ulcerative colitisFrancesc Casellas, Ana Gutiérrez-Casbas, Cristina Rodríguez, et al.
European Journal of Gastroenterology & Hepatology|December 9, 2021
Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot studyFernando Gomollón, Javier P Gisbert, Iván Guerra, et al.
JMIR Medical Informatics|February 18, 2022
Evaluation of Natural Language Processing for the Identification of Crohn Disease-Related Variables in Spanish Electronic Health Records: A Validation Study for the PREMONITION-CD ProjectCarmen Montoto, Javier P Gisbert, Iván Guerra, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2025
Assessing inflammatory bowel disease monitoring procedures in Spain: insights from the IBD-PODCAST studyJosé María Huguet, Elena Gómez Delgado, Saioa Rubio, et al.
Crohn'S & Colitis 360|February 14, 2023
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical PracticeMarta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, et al.
Revista Espanola De Enfermedades Digestivas|April 2, 2016
Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología DigestivaCristóbal de la Coba Ortiz, Federico Argüelles Arias, Carlos Martín de Argila de Prados, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 5, 2019
Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trialCarlos Taxonera, Antonio López-Sanromán, Isabel Vera-Mendoza, et al.
Journal of Crohn'S & Colitis|April 13, 2017
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised TrialAntonio López-Sanromán, Isabel Vera-Mendoza, Eugeni Domènech, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDACarla J Gargallo-Puyuelo, Elena Ricart, Eva Iglesias, et al.
Gastroenterologia Y Hepatologia|January 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel diseaseMarta Calvo Moya, Francisco Mesonero Gismero, Cristina Suarez Ferrer, et al.
Pageof 3